Literature DB >> 30461081

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer.

Masaki Shiota1, Ryo Namitome1, Takeshi Kobayashi1, Junichi Inokuchi1, Katsunori Tatsugami1, Masatoshi Eto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30461081     DOI： 10.1111/iju.13870

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  3 in total

1.  Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study.

Authors:  Takashi Kawahara; Shuko Yoneyama; Yoshio Ohno; Junpei Iizuka; Yasunobu Hashimoto; Hideyasu Tsumura; Ken-Ichi Tabata; Yoshihiro Nakagami; Kazunari Tanabe; Masatsugu Iwamura; Hiroji Uemura; Yasuhide Miyoshi
Journal:  Biomed Res Int       Date:  2020-07-01       Impact factor: 3.411

2.  Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer.

Authors:  Sotaro Chikamatsu; Masaki Shiota; Shigetomo Yamada; Leandro Blas; Takashi Matsumoto; Eiji Kashiwagi; Junichi Inokuchi; Ken-Ichiro Shiga; Akira Yokomizo; Masatoshi Eto
Journal:  Prostate Int       Date:  2022-01-11

3.  Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.

Authors:  Masaki Shiota; Naoki Terada; Toshihiro Saito; Akira Yokomizo; Naoki Kohei; Takayuki Goto; Sadafumi Kawamura; Yasuhiro Hashimoto; Atsushi Takahashi; Takahiro Kimura; Ken-Ichi Tabata; Ryotaro Tomida; Kohei Hashimoto; Toshihiko Sakurai; Toru Shimazui; Shinichi Sakamoto; Manabu Kamiyama; Nobumichi Tanaka; Koji Mitsuzuka; Takuma Kato; Shintaro Narita; Hiroaki Yasumoto; Shogo Teraoka; Masashi Kato; Takahiro Osawa; Yoshiyuki Nagumo; Hiroaki Matsumoto; Hideki Enokida; Takayuki Sugiyama; Kentaro Kuroiwa; Takahiro Inoue; Takashi Mizowaki; Toshiyuki Kamoto; Takahiro Kojima; Hiroshi Kitamura; Mikio Sugimoto; Hiroyuki Nishiyama; Masatoshi Eto
Journal:  Cancer Sci       Date:  2021-02-13       Impact factor: 6.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.